We aimed to screen our original cohort of 422 patients with SOD/congenital hypopituitarism, and develop a luciferase-reporter assay for novel functional assessment of detected KAL1 variants, using a reporter driven by an FGF-responsive osteocalcin promoter (Kim et al. The gene discussed is ANOS1; the disease is non-acquired combined pituitary hormone deficiency.